Drug intelligence / Profile preview

pantoprazole + domperidone

Development stage
Unknown
Lead developer
Ritz Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Pantz-DM is a combination oral tablet developed by Ritz Pharma, containing the proton pump inhibitor (PPI) pantoprazole and the dopamine antagonist domperidone. Pantoprazole works by irreversibly inhibiting the H+/K+-ATPase enzyme system (proton pump) in gastric parietal cells, thereby reducing gastric acid secretion. Domperidone acts as a peripheral dopamine D2 receptor antagonist with prokinetic properties, enhancing gastrointestinal motility and increasing lower esophageal sphincter pressure. This combination is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and symptoms associated with gastroparesis, such as nausea and vomiting.

Brand names
Pantz-DM
Other names
pantoprazole/domperidone
02

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)DRD2 (Dopamine D2 Receptor)

Beyond the preview

Go deeper on pantoprazole + domperidone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pantoprazole + domperidone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call